Research and Markets: The 'Molecular Diagnostics Conference 2008' Has Been Organized...

Research and Markets: The 'Molecular Diagnostics Conference 2008' Has Been Organized to Provide a Critical Examination of the Molecular Diagnostics Industry

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/6db71e/molecular_diagnost)
has announced the addition of the "Molecular Diagnostics Conference
2008" conference to their offering.

Conference Theme: Personalized Medicine through Genomic Analysis
and Molecular Diagnostics

-0-
*T
Monday, October 6, 2008
at
The Princeton Club of New York
located at
15 West 43rd Street (b/w Fifth and Sixth Avenues)
New York, New York, U.S.A. 10036
*T

The current price is an Early-Bird Registration Fee and lasts
until August 31, 2008. The price will increase on September 1, 2008

The 'Molecular Diagnostics Conference 2008' has been organized to
provide a critical examination of the molecular diagnostics industry,
as well as insight from key industry leaders concerning cutting edge
molecular diagnostics technology, structuring mutually beneficial
deals and the molecular diagnostics industry's impact on the field of
in vitro diagnostics. This conference will also provide an integral
forum for leaders in molecular diagnostics, in vitro diagnostics and
laboratories to share ideas, network with other delegates and advance
understanding of the potential of new molecular diagnostics
technologies.

-0-
*T
Who Should Attend:
-Molecular diagnostics companies.
-In vitro diagnostic companies.
-Biotechnology companies.
-Medical device manufacturers.

Leaders from the Following Areas Will Greatly Benefit from Attending:
-Laboratory leaders.
-Hospital CFOs and CSOs.
-Molecular diagnostics and in vitro diagnostic companies.
-Business development.
-Strategic planning and development.
-Technology development.
-Marketing.
-Research and development.

-Key Themes:
--A critical examination of key emerging technologies applicability to
molecular diagnostics.
--Formation of successful alliances.
--Partnering of emerging technologies with molecular diagnostics.
--Transitioning from laboratory in vitro diagnostics to molecular
diagnostics.
--The emerging role of molecular diagnostic tests in personalized
medicine.
--The intersection of pharmacogenomics and molecular diagnostics with
personalized medicine.

-Questions Answered in the TriMark Conference:
--What will the molecular diagnostics market be worth by the end of
the decade?
--Which market key segments will drive molecular diagnostics market
growth?
--Which new technologies will reach the molecular diagnostics market
in the next 2-3 years?
--How is technology innovation impacting the dynamics and ownership of
the molecular diagnostics industry?
--How can clinical labs bring in new molecular diagnostic tests?
--What are the key challenges in gaining acceptance of new
technologies by users, payers and regulators?
--How is technology innovation facilitating the transition of
molecular diagnostics testing into standard healthcare practice?

-Top Five Reasons To Attend the TriMark Conference:
--Discover the molecular diagnostics sectors with the greatest
prospective growth, ensuring you can successfully align your future
strategies with predicted success.
--Evaluate the competitive dynamics of the molecular diagnostics
market and understand the changing relationship between IVD companies
and the molecular diagnostics testing sector.
--Identify the key players in the molecular diagnostics market,
recognize lucrative partnering opportunities and benchmark your
strategies against the leading players.
--Assess opportunities and challenges faced by diagnostic companies in
gaining acceptance of innovative technologies by payers, regulators
and users.
--Understand the factors driving growth of the molecular diagnostics
market.

Registration at 8:00 am
Seated lunch at 12:00 pm
Cocktails/networking at 5:00 pm.
(Note: The Princeton Club has a business attire dress code.)
*T

For more information visit
http://www.researchandmarkets.com/research/6db71e/molecular_diagnost.

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2008